Lantheus Holdings (LNTH) Total Current Liabilities (2014 - 2026)
Lantheus Holdings (LNTH) reported Total Current Liabilities of $333.2 million for Q1 2026, up 34.34% year-over-year from $248.0 million in Q1 2025, and little changed quarter-over-quarter from $333.4 million in Q4 2025.
Lantheus Holdings (LNTH) Total Current Liabilities (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Total Current Liabilities data on file, last reported at $333.2 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $333.2 million, up 34.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $333.2 million (up 34.34% YoY), and the FY2025 annual result was $333.4 million, up 38.62% from the prior year.
- Total Current Liabilities steadied at $333.2 million in Q1 2026 per LNTH's latest filing, from $333.4 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $784.1 million in Q3 2024 and troughed at $154.0 million in Q2 2023.
- A 5-year average of $278.9 million and a median of $247.7 million in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities surged 343.98% in 2024, then plunged 55.76% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $247.7 million in 2022, then decreased by 24.36% to $187.4 million in 2023, then rose by 28.38% to $240.5 million in 2024, then jumped by 38.62% to $333.4 million in 2025, then retreated by 0.08% to $333.2 million in 2026.
- Business Quant data shows LNTH's Total Current Liabilities at $333.2 million in Q1 2026, $333.4 million in Q4 2025, and $346.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 333.17 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 618.78 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 149.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 333.17 Mn |
| Dec 31, 2025 | 333.42 Mn |
| Sep 30, 2025 | 346.84 Mn |
| Jun 30, 2025 | 280.13 Mn |
| Mar 31, 2025 | 248.00 Mn |
| Dec 31, 2024 | 240.53 Mn |
| Sep 30, 2024 | 784.08 Mn |
| Jun 30, 2024 | 263.29 Mn |
| Mar 31, 2024 | 237.20 Mn |
| Dec 31, 2023 | 187.35 Mn |
| Sep 30, 2023 | 176.60 Mn |
| Jun 30, 2023 | 154.04 Mn |
| Mar 31, 2023 | 276.39 Mn |
| Dec 31, 2022 | 247.70 Mn |
| Sep 30, 2022 | 235.98 Mn |
| Jun 30, 2022 | 219.02 Mn |
| Mar 31, 2022 | 177.66 Mn |
| Dec 31, 2021 | 90.50 Mn |
| Sep 30, 2021 | 76.90 Mn |
| Jun 30, 2021 | 73.83 Mn |